February 09, 2026

Managing Idiopathic Acute Pancreatitis

Expert panel weighs evidence for genetic testing, cholecystectomy, and ERCP in patients with unexplained acute pancreatitis amid limited guideline direction.

Conexiant

January 06, 2026

Scalpel, Sutures, and Separation Notices

National survey data reveal male and White surgeons at greatest risk for marital dissolution

Conexiant

January 02, 2026

Miami Cancer Institute Precision Oncology Symposium, Fourth Annual

This one-and-a-half-day symposium has been designed to provide an overview and opportunity to learn about the most recent advances in the treatment of solid tumors, including lung cancer, breast cancer, gastrointestinal tumors, genitourinary tumors, head and neck tumors, melanoma, sarcomas and brain tumors by novel targeted agents and treatment combinations.

Baptist Health South Florida

December 17, 2025

Building the Cancer Care Africa Deserves

There is something deeply moving about watching hope take shape, not as a slogan or a speech, but as people coming together to build the cancer care Africa deserves. The African Organization for Resea...

The ASCO Post

December 15, 2025

Genetic Testing Uncovers Hidden Cancer Risk

Population screening identifies pathogenic variants in patients who wouldn't qualify under current guidelines

Conexiant

December 09, 2025

SOHO 2025 Keynote Speakers Highlight Progress in Hematologic Oncology

Three Plenary Sessions were presented recently at the 2025 Annual Meeting of the Society of Hematologic Oncology (SOHO 2025), which focused specifically on new advances and practical clinical applicat...

The ASCO Post

December 04, 2025

Dana-Farber researchers present findings at 2025 San Antonio Breast Cancer Symposium

Physician scientists from Dana-Farber Cancer Institute will present more than 50 research studies at the 48th annual San Antonio Breast Cancer Symposium, December 9-12.

Dana-Farber

November 24, 2025

Oral PCSK9 Inhibitor Tied to LDL-C Drop

The oral PCSK9 inhibitor enlicitide decanoate achieved 58% LDL-C reduction in patients with heterozygous familial hypercholesterolemia, offering a potential alternative to injectable therapies.

Conexiant

November 21, 2025

Positive trends in chronic HCV mortality 

“DAAs have revolutionized the management of HCV by making it a curable disease.”

Conexiant